Fineline Cube

Follow:
14681 Articles
Walvax Initiates Phase I Trial of Lyophilized Shingles mRNA Vaccine – First‑in‑Class Herpes Zoster Candidate Co‑Developed with Fudan University and RQ Biotech
CompanyDrug

Walvax Initiates Phase I Trial of Lyophilized Shingles mRNA Vaccine – First‑in‑Class Herpes Zoster Candidate Co‑Developed with Fudan University and RQ Biotech

Keymed Biosciences' Stapokibart Wins Fourth NMPA Indication – Adolescent Atopic Dermatitis Approval as Kangyueda Revenue Surges 227%
CompanyDrug

Keymed Biosciences’ Stapokibart Wins Fourth NMPA Indication – Adolescent Atopic Dermatitis Approval as Kangyueda Revenue Surges 227%

ChemPartner and BioBAY Open Arsenal Innovation Center in Massachusetts – Bridging Suzhou and Boston Life Science Ecosystems
CompanyDeals

ChemPartner and BioBAY Open Arsenal Innovation Center in Massachusetts – Bridging Suzhou and Boston Life Science Ecosystems

Novo Nordisk's NovoGlic Wins Expanded NMPA Approval – First Weekly Insulin Icodec/Semaglutide Combination Broadens Type 2 Diabetes Care in China
CompanyDrug

Novo Nordisk’s NovoGlic Wins Expanded NMPA Approval – First Weekly Insulin Icodec/Semaglutide Combination Broadens Type 2 Diabetes Care in China

ArkBio Publishes Pivotal Phase 3 Data for Azstarys in Chinese Children with ADHD – NMPA‑Approved Dual‑Release Formulation Nears Commercial Launch
CompanyDrug

ArkBio Publishes Pivotal Phase 3 Data for Azstarys in Chinese Children with ADHD – NMPA‑Approved Dual‑Release Formulation Nears Commercial Launch

GenFleet's Oral KRAS G12D Inhibitor GFH375/VS‑7375 Delivers Positive Data Across Global Studies – World's First KRAS G12D Agent in Phase III for NSCLC and Pancreatic Cancer
CompanyDrug

GenFleet’s Oral KRAS G12D Inhibitor GFH375/VS‑7375 Delivers Positive Data Across Global Studies – World’s First KRAS G12D Agent in Phase III for NSCLC and Pancreatic Cancer

Centergate Technologies Subsidiary Duoduo Pharmaceutical Has Calcium Dobesilate Capsules Application Accepted by NMPA – Generic Filing Enters Review for Established Capillary Protectant
CompanyDrug

Centergate Technologies Subsidiary Duoduo Pharmaceutical Has Calcium Dobesilate Capsules Application Accepted by NMPA – Generic Filing Enters Review for Established Capillary Protectant

Tasly Pharmaceutical Receives NMPA Clinical Trial Approval for TDX105 Granules – Category 1.1 TCM Innovative Drug Targeting Chemotherapy‑Induced Hand‑Foot Skin Reactions
CompanyDrug

Tasly Pharmaceutical Receives NMPA Clinical Trial Approval for TDX105 Granules – Category 1.1 TCM Innovative Drug Targeting Chemotherapy‑Induced Hand‑Foot Skin Reactions

Sino Biopharmaceutical's Hepatitis B Assets Take Center Stage at AASLD 2026 – Bepirovirsen Phase 3 Functional Cure Data and TQ‑A3334 Late‑Breaking Phase II Results Slated for Oral Presentation
CompanyDrug

Sino Biopharmaceutical’s Hepatitis B Assets Take Center Stage at AASLD 2026 – Bepirovirsen Phase 3 Functional Cure Data and TQ‑A3334 Late‑Breaking Phase II Results Slated for Oral Presentation

Vir Biotechnology and Gilead Strike Collaboration to Engineer Three PRO‑XTEN Dual‑Masked T‑Cell Engagers – Deal Worth Up to USD 1.88 Billion in Milestones
CompanyDeals

Vir Biotechnology and Gilead Strike Collaboration to Engineer Three PRO‑XTEN Dual‑Masked T‑Cell Engagers – Deal Worth Up to USD 1.88 Billion in Milestones

Merck Inaugurates ADVANCE Research Facility in West Point, Pennsylvania – AI‑Powered Automation Hub to Accelerate Global Drug Development
Company

Merck Inaugurates ADVANCE Research Facility in West Point, Pennsylvania – AI‑Powered Automation Hub to Accelerate Global Drug Development

Chipscreen Biosciences Secures NMPA IND Acceptance for CS23546 – Oral Small‑Molecule PD‑L1 Inhibitor Advancing in Relapsed or Refractory Lymphoma
CompanyDrug

Chipscreen Biosciences Secures NMPA IND Acceptance for CS23546 – Oral Small‑Molecule PD‑L1 Inhibitor Advancing in Relapsed or Refractory Lymphoma